Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (481-490 of 509) with videos related to

Pageof 51
Sort By:
Gynecologic Oncology|May 3, 2021
Uterine serous carcinomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european studyFabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
The Lancet. Oncology|December 3, 2016
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trialElizabeth M Swisher, Kevin K Lin, Amit M Oza, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancerAndreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
Reproductive Biomedicine Online|May 7, 2022
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivorsManon Mangiardi-Veltin, Clara Sebbag, Christine Rousset-Jablonski, et al.
BMC Cancer|May 29, 2021
Determinants of the access to remote specialised services provided by national sarcoma reference centresYohan Fayet, Raphaël Tétreau, Charles Honoré, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Pageof 51

Showing results (481-490 of 509) with videos related to

Sort By:
Pageof 51
Gynecologic Oncology|May 3, 2021
Uterine serous carcinomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2022
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european studyFabio Conforti, Alessandro Gronchi, Nicholas Penel, et al.
The Lancet. Oncology|December 3, 2016
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trialElizabeth M Swisher, Kevin K Lin, Amit M Oza, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancerAndreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
Reproductive Biomedicine Online|May 7, 2022
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivorsManon Mangiardi-Veltin, Clara Sebbag, Christine Rousset-Jablonski, et al.
BMC Cancer|May 29, 2021
Determinants of the access to remote specialised services provided by national sarcoma reference centresYohan Fayet, Raphaël Tétreau, Charles Honoré, et al.
International Journal of Cancer|March 30, 2019
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 yearsClémence Basse, Antoine Italiano, Nicolas Penel, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Pageof 51